
CAS 2102933-95-7
:Formula:C14H22Cl2N2
InChI:InChI=1S/C14H20N2.2ClH/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12;;/h1-5,12-16H,6-10H2;2*1H/t13-,14+;;/m0../s1
InChI key:PJFZOGMSPBHPNS-WICJZZOFSA-N
SMILES:C1CNCCC1N[C@@H]2C[C@H]2C3=CC=CC=C3.Cl.Cl
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
GSK-LSD1 dihydrochloride
CAS:GSK-LSD1 dihydrochlorideFormula:C14H22Cl2N2Purity:98.5%Molecular weight:289.24GSK-LSD1 dihydrochloride
CAS:GSK-LSD1 dihydrochloride: potent LSD1 inhibitor, >1000x selective over MAO-A/B, LSD2, IC50: 16 nM.Formula:C14H22Cl2N2Purity:98.72% - >99.99%Color and Shape:Yellow SolidMolecular weight:289.24GSK LSD1 Dihydrochloride
CAS:Controlled ProductApplications GSK LSD1 Dihydrochloride is an irreversible mechanism-based inhibitor of LSD1. Lysine-specific demthylase 1 (LSD1) belonges to the flavin adenine dinucleotide (FAD) family-dependant amine oxidases that include MAOs and PAOs. Inhibits cell proliferation in cancer cell lines.
References Shi, Y. et al.: Cell 119, 941 (2004); Forneris, F. J. Biol. Chem. 280, 41360 (2005);Formula:C14H22Cl2N2Color and Shape:NeatMolecular weight:342.407GSK-LSD1 dihydrochloride
CAS:GSK-LSD1 is a potential drug for the treatment of cervical cancer and myeloid leukemia. GSK-LSD1 has been shown to induce autophagy, which is a process by which cells break down and recycle their own cellular components. This process also plays a key role in the development of bowel disease, as well as inflammatory bowel disease and leukemias. GSK-LSD1 was shown to inhibit the growth of human myeloid leukemia cells (THP-1) in vitro and reduced the number of leukemic mice with leukemia. The mechanism by which GSK-LSD1 inhibits tumor cell proliferation is unclear, but may be related to its ability to inhibit cell factor or stem cell factor expression.Formula:C14H22Cl2N2Purity:Min. 95%Molecular weight:289.24 g/mol





